Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semen Quality in a Large Cohort of Males Living in Highly Polluted Areas of Campania Region in Southern Italy with a Focus on the Role of Cadmium Exposure.

Journal of clinical medicine·2026
Same author

Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer models.

European journal of medicinal chemistry·2026
Same author

"Testicular concentrations of metals and metalloids in dogs from the 'Land of Fires' (Campania Region, Italy): a preliminary morphological, chemical and molecular study".

Environmental toxicology and pharmacology·2026
Same author

Mono- vs. Bis-Guanyl Hydrazone-Decorated Tricyclic Scaffolds: Effects on G-Quadruplex Binding and Selectivity.

International journal of molecular sciences·2026
Same author

F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant <i>C. albicans</i>: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress.

ACS infectious diseases·2026
Same author

Upcycling lemon peel waste into sustainable bioactive ingredients: chemical characterization and efficacy assessment.

The Analyst·2026

Related Experiment Video

Updated: Sep 3, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Bioengineered lipophilic Ru(III) complexes as potential anticancer agents.

Claudia Riccardi1, Marialuisa Piccolo2, Maria Grazia Ferraro2

  • 1Department of Chemical Sciences, University of Naples "Federico II", Via Cintia 21, 80126 Naples, Italy.

Biomaterials Advances
|July 26, 2022
PubMed
Summary

Novel lipid-conjugated Ruthenium(III) complexes demonstrate enhanced antiproliferative activity against breast cancer cells. These lipophilic complexes show improved cell uptake and selective targeting, offering a promising new avenue for cancer therapy.

Keywords:
Antiproliferative activityCell uptakeDNA/BSA binding studyLipid conjugatesNanoaggregatesRuthenium(III) complexes

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K

Related Experiment Videos

Last Updated: Sep 3, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Biophysics

Background:

  • AziRu is a NAMI-A-like anticancer agent.
  • Lipid conjugation aims to create lipophilic analogues of AziRu.
  • Ruthenium(III) complexes are investigated for anticancer properties.

Purpose of the Study:

  • Synthesize and characterize novel lipid-conjugated Ru(III) complexes.
  • Investigate their molecular and self-assembling properties.
  • Evaluate their antiproliferative activity and cellular uptake in breast cancer models.

Main Methods:

  • Synthesis and full characterization of Ru(III) complexes.
  • Biophysical investigations using integrated techniques.
  • In vitro biological experiments and spectroscopic analysis.
  • Inductively coupled plasma-mass spectrometry (ICP-MS) for cell uptake studies.

Main Results:

  • Lipid-conjugated Ru(III) complexes (PalmiPyRu, StePyRu) were synthesized.
  • These complexes exhibit protective effects against hydrolysis and form aggregates.
  • PalmiPyRu and StePyRu show promising, selective antiproliferative activity against breast cancer phenotypes.
  • Higher cell uptake of lipophilic complexes compared to AziRu was observed.
  • Binding interactions with bovine serum albumin (BSA) and DNA structures were investigated.

Conclusions:

  • Lipid conjugation enhances the properties of Ru(III) anticancer agents.
  • Lipophilic Ru(III) complexes demonstrate improved cell membrane penetration and antiproliferative efficacy.
  • These findings support the potential of lipid-conjugated Ru(III) complexes as targeted breast cancer therapeutics.